Skip to main content

Table 2 Baseline characteristics of each group

From: Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessation

 

Early

Obvious

Severe

Age (years)

63 (57–74)

65 (48–75)

74 (63–76)

Cumulative dose (g)

730 (438–949)

1933 (584–4380)

1030 (890–1679)

Baseline vision

20/20–20/40

20/20–20/60

20/100–20/400

Follow-up (months)

13 (12–56)

36 (12–56)

14 (13–36)

  1. Median (range) reported for age, cumulative dose, and follow-up
Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us